66 related articles for article (PubMed ID: 23649842)
21. Urine-to-plasma creatinine ratio and fractional excretion of urea performance in acute-on-chronic kidney disease patients.
Lievre L; Dupont V; Kanagaratnam L; Faroux L; Debrumetz A; Rieu P; Wynckel A
J Nephrol; 2023 Dec; 36(9):2661-2663. PubMed ID: 37402076
[No Abstract] [Full Text] [Related]
22. [The efficiency of pre-administration of a peptide mimicking the spatial structure of erythropoietin -chain B in modeling experimental post-contrast acute kidney injury].
Bratchikov O I; Kondrashov M M; Kostina D A; Shcheblykina O V
Urologiia; 2023 Dec; (6):64-67. PubMed ID: 38156685
[TBL] [Abstract][Full Text] [Related]
23. The renal damage and mechanisms relevant to antitumoral drugs.
Tang J; Yang N; Pan S; Ren P; Chen M; Jin J; He Q; Zeng Y
Front Oncol; 2023; 13():1331671. PubMed ID: 38148845
[TBL] [Abstract][Full Text] [Related]
24. Identification of Novel Biomarkers for Predicting Kidney Injury Due to Drugs Using "Omic" Strategies.
Awdishu L; Atilano-Roque A; Tuey S; Joy MS
Pharmgenomics Pers Med; 2020; 13():687-705. PubMed ID: 33293850
[TBL] [Abstract][Full Text] [Related]
25. The urinary excretion of an organic anion transporter as an early biomarker of methotrexate-induced kidney injury.
Severin MJ; Trebucobich MS; Buszniez P; Brandoni A; Torres AM
Toxicol Res (Camb); 2016 Mar; 5(2):530-538. PubMed ID: 30090367
[TBL] [Abstract][Full Text] [Related]
26. The 6R's of drug induced nephrotoxicity.
Awdishu L; Mehta RL
BMC Nephrol; 2017 Apr; 18(1):124. PubMed ID: 28372552
[TBL] [Abstract][Full Text] [Related]
27. Renal Expression and Urinary Excretion of Na-K-2Cl Cotransporter in Obstructive Nephropathy.
Brandoni A; Torres AM
Biomed Res Int; 2017; 2017():7171928. PubMed ID: 28164127
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury.
Bajwa A; Rosin DL; Chroscicki P; Lee S; Dondeti K; Ye H; Kinsey GR; Stevens BK; Jobin K; Kenwood BM; Hoehn KL; Lynch KR; Okusa MD
J Am Soc Nephrol; 2015 Apr; 26(4):908-25. PubMed ID: 25145931
[TBL] [Abstract][Full Text] [Related]
29. Organic anion transporter 5 renal expression and urinary excretion in rats with vascular calcification.
Hazelhoff MH; Bulacio RP; Torres AM
Biomed Res Int; 2013; 2013():283429. PubMed ID: 24199190
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of Cisplatin nephrotoxicity.
Miller RP; Tadagavadi RK; Ramesh G; Reeves WB
Toxins (Basel); 2010 Nov; 2(11):2490-518. PubMed ID: 22069563
[TBL] [Abstract][Full Text] [Related]
31. Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapy.
George B; Wen X; Mercke N; Gomez M; O'Bryant C; Bowles DW; Hu Y; Hogan SL; Joy MS; Aleksunes LM
Toxicol Rep; 2020; 7():571-576. PubMed ID: 32382514
[TBL] [Abstract][Full Text] [Related]
32. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842
[TBL] [Abstract][Full Text] [Related]
33. Time course of organic anion transporter 5 (Oat5) urinary excretion in rats treated with cisplatin: a novel urinary biomarker for early detection of drug-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2015 Aug; 89(8):1359-69. PubMed ID: 25164828
[TBL] [Abstract][Full Text] [Related]
34. Organic anion transporter 5 renal expression and urinary excretion in rats exposed to mercuric chloride: a potential biomarker of mercury-induced nephropathy.
Di Giusto G; Torres AM
Arch Toxicol; 2010 Oct; 84(10):741-9. PubMed ID: 20407758
[TBL] [Abstract][Full Text] [Related]
35. Organic Anion Transporter 5 (Oat5) Urinary Excretion Is a Specific Biomarker of Kidney Injury: Evaluation of Urinary Excretion of Exosomal Oat5 after N-Acetylcysteine Prevention of Cisplatin Induced Nephrotoxicity.
Bulacio RP; Anzai N; Ouchi M; Torres AM
Chem Res Toxicol; 2015 Aug; 28(8):1595-602. PubMed ID: 26230185
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
